4//SEC Filing
Stehman-Breen Catherine 4
Accession 0000899243-21-020992
CIK 0001818794other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 8:43 PM ET
Size
5.3 KB
Accession
0000899243-21-020992
Insider Transaction Report
Form 4
Stehman-Breen Catherine
Director
Transactions
- Award
Stock Option (right to buy)
2021-05-26+19,596→ 19,596 totalExercise: $19.56Exp: 2031-05-25→ Common Stock (19,596 underlying)
Footnotes (1)
- [F1]This option was granted on May 26, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 26, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001702233
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 8:43 PM ET
- Size
- 5.3 KB